Jan 16 (Reuters) - Mylan has agreed to pay $73.5 million to settle a class action lawsuit by drug wholesalers accusing the drugmaker of scheming to overcharge them for EpiPen allergy treatment ...

Mylan’s EpiPen, which generated sales of $442m ... "ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for $145m" was originally created and published by Pharmaceutical Technology ...